Clinical Trials Directory

Trials / Completed

CompletedNCT04899999

Graphic Messages to Prevent E-Cigarette Use Among Black and Latino Adolescents

Graphic Messages to Prevent E-Cigarette Use Among Latino and African American Adolescents: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
362 (actual)
Sponsor
University of Rochester · Academic / Other
Sex
All
Age
12 Years – 17 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to determine if graphic messages prevent future vaping use among African American and Latino adolescents. The images have been developed in a user-design model and include four main themes: health reward, financial reward, self-efficacy, and social norms. We will assess pre- and post-exposure reactions on likelihood of future vaping among African American and Latino adolescents.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFinancial reward graphic messageGraphic image will be shared with the participants online once in either English or Spanish depending on their language of preference. Image includes the following text: Vaping leads to nothing. Don't let your money vaporize away.
BEHAVIORALHealth reward graphic messageGraphic image will be shared with the participants online once in either English or Spanish depending on their language of preference. Image includes the following text: Dying for a vape? It hurts more than you know.
BEHAVIORALSelf-efficacy graphic messageGraphic image will be shared with the participants online once in either English or Spanish depending on their language of preference. Image includes the following text: Vaping companies are targeting Black and Latino teens. Your life matters. Don't let them take it away.
BEHAVIORALSocial norms graphic messageGraphic image will be shared with the participants online once in either English or Spanish depending on their language of preference. Image includes the following text: Just because vaping is common, doesn't mean it's cool. Stay woke. Don't smoke.

Timeline

Start date
2021-08-06
Primary completion
2021-12-15
Completion
2021-12-15
First posted
2021-05-25
Last updated
2025-08-01
Results posted
2025-08-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04899999. Inclusion in this directory is not an endorsement.